Medications
Patient information about medications commonly prescribed for neuro-ophthalmology conditions. Each guide covers how the medication works, dosing, and potential side effects.
40 medication guides reviewed by board-certified specialists
Related: Conditions treated • Other treatments
Eculizumab (Soliris)
A biologic that blocks complement, FDA-approved for NMO to prevent relapses.
Rituximab (Rituxan)
A biologic medication that targets B cells, used for NMO, myasthenia gravis, and other autoimmune conditions.
Teprotumumab (Tepezza)
The first FDA-approved medication specifically for thyroid eye disease, targeting IGF-1 receptor.
Tocilizumab (Actemra)
An IL-6 inhibitor used for giant cell arteritis and neuromyelitis optica.
Eysuvis (Loteprednol 0.25%)
A low-dose steroid eye drop specifically approved for short-term treatment of dry eye disease flares.
Loteprednol (Lotemax, Eysuvis)
A 'soft' steroid eye drop for treating eye inflammation with lower risk of pressure elevation than traditional steroids.
Methylprednisolone (IV Steroids)
High-dose intravenous corticosteroid used for acute inflammatory conditions affecting vision.
Prednisone (Oral Steroids)
A corticosteroid medication used to reduce inflammation in many neuro-ophthalmic conditions.
Rocklatan (Netarsudil/Latanoprost)
Combination eye drops for glaucoma containing a rho kinase inhibitor and prostaglandin analog to lower eye pressure.
Simbrinza (Brinzolamide/Brimonidine)
Combination eye drops for glaucoma containing a carbonic anhydrase inhibitor and alpha agonist to lower eye pressure.
Azathioprine (Imuran)
An immunosuppressant medication used as a steroid-sparing agent for various autoimmune conditions.
Methotrexate
An immunosuppressant used as a steroid-sparing agent for inflammatory and autoimmune conditions.
Mycophenolate (CellCept/Myfortic)
An immunosuppressant medication used for autoimmune conditions, often as a steroid-sparing agent.